[PHARMA] QoQ TTM Result on 31-Mar-2003 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-May-2003
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2003
Quarter
31-Mar-2003 [#1]
Profit Trend
QoQ- 11.53%
YoY- 40.31%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Revenue 632,604 595,774 596,928 599,086 585,237 594,966 578,889 6.07%
PBT 66,841 59,464 62,072 65,591 61,170 64,797 58,312 9.50%
Tax -26,085 -21,424 -23,185 -23,946 -23,829 -26,084 -24,033 5.59%
NP 40,756 38,040 38,887 41,645 37,341 38,713 34,279 12.19%
-
NP to SH 40,756 38,040 38,887 41,645 37,341 38,713 34,279 12.19%
-
Tax Rate 39.03% 36.03% 37.35% 36.51% 38.96% 40.25% 41.21% -
Total Cost 591,848 557,734 558,041 557,441 547,896 556,253 544,610 5.68%
-
Net Worth 222,586 211,489 194,744 192,761 179,444 172,829 159,457 24.82%
Dividend
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Div 18,045 8,506 3,744 3,744 3,744 5,002 3,750 184.21%
Div Payout % 44.28% 22.36% 9.63% 8.99% 10.03% 12.92% 10.94% -
Equity
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Net Worth 222,586 211,489 194,744 192,761 179,444 172,829 159,457 24.82%
NOSH 100,263 100,232 99,869 100,396 99,691 50,095 49,986 58.84%
Ratio Analysis
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
NP Margin 6.44% 6.38% 6.51% 6.95% 6.38% 6.51% 5.92% -
ROE 18.31% 17.99% 19.97% 21.60% 20.81% 22.40% 21.50% -
Per Share
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
RPS 630.94 594.39 597.71 596.72 587.05 1,187.67 1,158.09 -33.22%
EPS 40.65 37.95 38.94 41.48 37.46 77.28 68.58 -29.37%
DPS 18.00 8.50 3.75 3.73 3.76 10.00 7.50 78.97%
NAPS 2.22 2.11 1.95 1.92 1.80 3.45 3.19 -21.41%
Adjusted Per Share Value based on latest NOSH - 100,396
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
RPS 43.89 41.34 41.42 41.57 40.61 41.28 40.17 6.06%
EPS 2.83 2.64 2.70 2.89 2.59 2.69 2.38 12.20%
DPS 1.25 0.59 0.26 0.26 0.26 0.35 0.26 184.04%
NAPS 0.1544 0.1467 0.1351 0.1337 0.1245 0.1199 0.1106 24.83%
Price Multiplier on Financial Quarter End Date
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Date 31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 28/06/02 -
Price 4.82 4.55 4.07 3.64 3.80 7.68 7.32 -
P/RPS 0.76 0.77 0.68 0.61 0.65 0.65 0.63 13.28%
P/EPS 11.86 11.99 10.45 8.78 10.15 9.94 10.67 7.28%
EY 8.43 8.34 9.57 11.40 9.86 10.06 9.37 -6.78%
DY 3.73 1.87 0.92 1.02 0.99 1.30 1.02 136.79%
P/NAPS 2.17 2.16 2.09 1.90 2.11 2.23 2.29 -3.51%
Price Multiplier on Announcement Date
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Date 19/02/04 14/11/03 19/08/03 20/05/03 10/04/03 22/11/02 26/08/02 -
Price 5.23 5.00 4.73 3.69 3.62 7.36 7.86 -
P/RPS 0.83 0.84 0.79 0.62 0.62 0.62 0.68 14.17%
P/EPS 12.87 13.17 12.15 8.90 9.66 9.52 11.46 8.01%
EY 7.77 7.59 8.23 11.24 10.35 10.50 8.72 -7.38%
DY 3.44 1.70 0.79 1.01 1.04 1.36 0.95 135.25%
P/NAPS 2.36 2.37 2.43 1.92 2.01 2.13 2.46 -2.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment